Optimizing the use of data generated by geriatric depression treatment studies during a time of diminishing resources

American Journal of Geriatric Psychiatry

Volumn 15, Issue 7, 2007, Pages 545-552

  Meyers, Barnett S ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Payne Whitney Westchester   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

AGING; BRAIN FUNCTION; CLINICAL TRIAL; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFICACY; GENOTYPE; GERIATRIC CARE; GERIATRIC DEPRESSION; GERIATRIC PATIENT; GERONTOPSYCHIATRY; HAMILTON SCALE; HIGH RISK BEHAVIOR; HUMAN; MAINTENANCE THERAPY; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROIMAGING; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RELAPSE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROKE; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; TREATMENT RESPONSE; VASCULAR DEPRESSION; VASCULAR DISEASE; AGED; ECONOMICS; HEALTH CARE COST; HEALTH CARE PLANNING; NOTE; ONSET AGE; ORGANIZATION AND MANAGEMENT; RECURRENT DISEASE; STATISTICS; UNITED STATES;

AGE OF ONSET; AGED; DEPRESSIVE DISORDER, MAJOR; GERIATRIC PSYCHIATRY; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SUICIDE, ATTEMPTED; UNITED STATES;

EID: 34548097883     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3180959df5     Document Type: Editorial

References (41)

1. Sneed JR, Roose SP, Keilp JG, et al: Response Inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry 2007; 15:553-563
2. Roose SP, Sackeim HA, Krishnan KR, et al: Antidepressant pharmacotherapy in the treatment of depression in the very old: A randomized, placebo-controlled trial. Am J Psychiatry 2004; 161:2050-2059
3. Alexopoulos GS, Meyers BS, Young RC, et al: Clinically Defined Vascular Dementia. Am J Psychiatry 1997; 154:562-565
4. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
5. Alexopoulos GS: "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? Am J Geriatr Psychiatry 2001; 9:22-91
6. Kondo DG, Speer MC, Krishnan KR: Association of AGTR1 with 18-month treatment outcome in late-life depression. Am J Geriatr Psychiatry 2007; 15:564-572
7. Rubattu S, Di Angelantonio E, Stanzione R, et al: Gene polymorphisms of the rennin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J Hypertens 2004; 22:2129-2134
8. Nelson CJ, Delucchi K, Schneider LS: Suicidal thinking and behavior during treatment with sertraline in late-life depression. Am J Geriatr Psychiatry 2007; 15:573-580
9. Schneider LS, Nelson JC, Clary CM, et al: An eight-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 2003; 160:1277-1285
10. Gorwood PA, Weiller E, Lemming O, Katona C: Escitalopram prevents relapse in older patients with Major Depressive Disorder. Am J Geriatr Psychiatry 2007; 15:581-593
11. Healy D: Let Them Eat Prozac: The Unhealthy Relationship between the Pharmaceutical Industry and Depression. New York, New York University Press, 1994
12. Meyers BS, Alexopoulos GS: Age of Onset and Geriatric Depression. Int J Geriatric Psychiatry 1988; 3:219-228
13. Alexopoulos GS, Meyers BS, Young RC, et al: Brain Changes and Geriatric Depression. Int J Geriatric Psychiatry 1988; 3:157-161
14. Coffey CE, Figiel GS, Jiang WT, et al: Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 1988; 24:143-161
15. Simpson S, Jackson A, Baldwin RC, et al: Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsycholgical impairment. Int Psychogeriatrics 1997; 9:257-275
16. Golden CJ: The Stroop Color Word test: A manual for experimental use. Wood Dale, IL, Stoelting, 1978
17. Mattis S: Dementia rating scale professional manual. Odessa, FL, Psychological Assessment Resources, 1989
18. Alexopoulos GS, Kiosses DN, Heo M, et al: Exectuive dysfunction and the course of geriatric depression. Biol Psychiatry 2005; 58:205-210
19. Alexopoulos GS: Frontostriatal-limbic dysfunction in late-life depression. Am J Geriatr Psychiatry 2002; 10:687-695
20. Alexopoulos GS: The vascular depression hypothesis: 10 years later. Biol Psychiatry 2006; 60:1304-1305
21. Glassman AH, O'Connor CM, Califf RM, et al: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709
22. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
23. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiat 1979; 134:382-389
24. Georgotas A, McCue RE, Hapworth W, et al: Comparative efficacy of and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 1986; 21:1155-1166
25. Judd LL, Paulus MP, Zeller P: The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Arch Gen Psychiatry 1999; 56:764-765
26. Taylor WD, Steffens DC, Krishnan KR: Psychiatric Disease in the twenty-first century: the case for subcortical ischemic depression. Biol Psychiatry 2006; 60:1299-1303
27. Reynolds CF, Amande Dw M, Pollock BG, et al: Maintenance treatment of major depression in old age. NEJM 2006; 354:1130-1158
28. Alexopoulos GS, Katz IR, Reynold CF, et al: Pharmacotherapy of depressive disorders in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 2001; 7:361-376
29. Zimmerman M, Chelminski I, Posternak M: A review of studies of the Hamilton Depresion Rating Scale in health controls: implications for the definition of remission in treatment studies of depression. J Nervous Mental Dis 2004; 192:595-601
30. Butters MA, Bhalla RK, Mulsant BH, Mazumdar S, et al: Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression. Is there a relationship? 2004; 12:387-394
31. Alexopoulos GS, Meyers BS, Young RC, et al: Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000; 57:285-290
32. Hammad T: Review and evaluation of clinical data. Available at: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads- review.pdf
33. Arias E, Anderson RN, Kung HC, et al: Deaths: Final Data for 2001: National Vital Statistics Reports 52 (3). Hyattsville, MD, National Center for Health Statistics. US Department of Health and Human Services publication (DHS), 2003
34. Conwell Y, Duberstein PR, Caine ED: Risk factors for suicide in later life. Biol Psychiatry 2002; 52:193-204
35. Juurlink DN, Mamdani M, Kopp A, et al: The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry 2006; 163:313-821
36. Stone Mg, Jones ML: FDA Clinical Review: Relationship between antidepressant drugs and suicidality in adults. Washington, DC, US Food and Drug Administration, 2006, pp 1-64
37. Gibbons RD, Hur K, Bhaumik DK et al: The relationship between antidepressant use and rate of suicide. Arch Gen Psychiatry 2005; 162:165-172
38. Posner K, Oquendo MA, Stanley B, et al: Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicide risk analysis of antidepressants. Am J Psychiatry 2007; in press
39. Bruce ML, Ten Have TR, Reynolds CF, et al: Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 2004; 291:1081-1091
40. Beck AT, Kovacs M, Weissman A: Assessment of Suicidal Intention: The Scale for Suicidal Ideation. J Consult Clin Psychol 1979; 47:343-352
41. Meyers BS, English J, Heo M, et al: Clinical and neuropsychological features of psychotic major depression: age effects. International Psychogeriatrics 2005; 17:138